Company Filing History:
Years Active: 2012-2025
Title: Ian Harwigsson: Innovator in Opioid Formulations
Introduction
Ian Harwigsson is a notable inventor based in Lund, Sweden, recognized for his contributions to the field of opioid formulations. With a total of 11 patents to his name, he has made significant strides in pain management and related therapies.
Latest Patents
One of his latest patents is an injectable buprenorphine formulation. This invention provides an injectable liquid formulation that includes a controlled-release matrix, at least one oxygen-containing organic solvent, and a minimum of 12% by weight of an active agent selected from buprenorphine and its salts, calculated as buprenorphine free base. This formulation aims to enhance treatment methods in pain management through opioid maintenance and related methods.
Career Highlights
Throughout his career, Ian has worked with companies such as Camurus AB and Camarus AB, where he has applied his expertise in developing innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of opioid formulations.
Collaborations
Ian has collaborated with notable colleagues, including Fredrik Tiberg and Markus Johnsson, contributing to the development of effective pain management therapies.
Conclusion
Ian Harwigsson's innovative work in opioid formulations has made a significant impact on pain management strategies. His contributions continue to influence the pharmaceutical industry and improve patient care.